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Role of Enterovirus 71 in Acute Flaccid Paralysis After the
Eradication of Poliovirus in Brazil
As a result of the successful initiative to eradi-
cate poliomyelitis in the Americas, Brazil is now free
of circulating wild poliovirus. The last cases of acute
flaccid paralysis (AFP) with confirmed wild poliovi-
rus isolation occurred in March 1989 (1). Since the
elimination of wild poliovirus-associated poliomy-
elitis in Brazil and the American region by intensive
mass vaccination campaigns, acute paralytic ill-
nesses from other causes constitute a greater
proportion of suspected cases. Enterovirus 71 (EV71)
can cause paralytic disease with persistent flaccid
paralysis (which may be confused with paralysis
caused by wild polioviruses); therefore, the presence
of this enterovirus in a community may complicate
the evaluation of poliomyelitis control progress. Se-
rologic evidence of EV71 infections (demonstrated
by neutralization assays) has been observed in AFP
patients in Brazil (9). In addition, EV71 isolates have
been obtained from patients with suspected cases
of poliomyelitis and their healthy contacts from dif-
ferent areas in Brazil and from AFP patients in Peru
and Bolivia (3, Ferreira et al., in preparation).
EV71, the most recently recognized human en-
terovirus in the family Picornaviridae, has been
associated with outbreaks of hand-foot-and-mouth
disease and central nervous system diseases (e.g.,
aseptic meningitis, encephalitis, and poliomyelitis-
like paralytic diseases) with persistent or transient
paralysis (2,4,5). Despite some understanding of the
variability in clinical manifestations and epidemio-
logic pattern, little is known about the contribution
of EV71 to overall AFP in different countries.
Immunoglobulin M (IgM) antibody to EV71 was
measured by using an µ-capture enzyme immunoas-
say (EIA) (6). The antigen was prepared from the
BrCr strain of EV71, and biotinylated anti-EV71
monoclonal antibody as detector was also prepared
(6). The results were expressed as the difference in
mean optical density values measured in triplicate
wells of positive antigen (P) and negative controls
(N). A specimen was considered positive if the ob-
served P-N was > 2 standard deviations (SD) above
the mean of the optical densities for the negative
control serum (P-N > 0.25).
Serum samples were obtained from 92 infants
from different regions of Brazil who had suspected
poliomyelitis and symptoms of AFP during 1989 and
1990. The 138 samples included paired serum
samples (S1 and S2) from 46 patients (92 sera) and
46 serum samples (S1 only) from 46 patients. Acute-
phase serum samples (S1) were obtained 1 to 15 days
after the onset of symptoms, and a second group of
samples were obtained (S2) 15 to 45 days later; all
were from children whose stool specimens were
negative for wild poliovirus.
To check the assay reagent cross-reactivity with
polioviruses, all 138 serum specimens were tested
in parallel by the same described method, but by
using poliovirus serotypes 1, 2, and 3 Sabin strains
instead of EV71 as the antigen. The assay had also
been checked in a limited fashion for heterotypic
response due to poliovirus infection by testing sera
from a limited number of known vaccine-associated
paralytic poliomyelitis cases (4). These vaccine as-
sociated case sera showed no evidence of IgM
response to EV71 antigen from poliovirus infection.
Specimens from 20 of 92 patients with suspected
cases of poliomyelitis had positive IgM responses to
EV71 (Table). Three patients (2287, 3805, and 3489)
whose specimens were positive had only a single
serum specimen (S1) available. Four serum speci-
mens (1819, 2018, 1918, and 1906) only had positive
IgM titers for the first serum (S1), and five speci-
mens from Bahia State (429, 784, 1130, 1325, and
780) had an IgM response only for the convalescent-
phase sera (S2). The IgM-positive AFP specimens
were from residents of eight widely dispersed re-
gions of Brazil with eight specimens collected in 1989
and 12 collected in 1990. Six of 19 AFP patients with
IgM positive results had residual paralysis after 60
days, which is considered to be clinically character-
istic of poliomyelitis due to poliovirus. The
remainder of the AFP patients only had a transient
paralysis from which they recovered.
The presence of residual paralysis and EV71 IgM
antibodies in 20 (21.7%) of the 92 AFP patients from
eight geographic regions indicates that EV71 may
be causing AFP-like poliomyelitis throughout Bra-
zil. The incidence of EV71 infection associated with
AFP in Brazil is high when compared with its inci-
dence in the United States, where EV71 infections
leading to AFP are very uncommon but have rates
not much lower than those of vaccine-associated
paralytic poliomyelitis (5,8). Poliomyelitis-like para-
lytic illnesses in Brazil in 1989 and 1990 are not
likely attributable to polioviruses; most of these
cases occurred after the last confirmed case of wild
poliovirus paralysis, and poliovirus was not isolated
from any patient’s stool specimens. EV71 causes per-
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nonpolio enteroviruses cannot be excluded, the pos-
sibility can only be addressed directly by additional
testing with other serologic assays. However, when
the same assay was used to examine specimens from
known cases of vaccine-associated paralytic polio-
myelitis from the United States, no heterotypic
response was observed (4).
Since 1990, for technical and operational reasons,
serologic methods have not been used to confirm
cases of AFP as caused by wild poliovirus; there-
fore, serum samples are no longer available for
routine poliovirus diagnosis. Our recent efforts have
been directed towards isolating and characterizing
nonpolio enteroviruses (with emphasis on EV71)
from patients with suspected poliomyelitis and to-
wards examining the geographic and temporal
relationship between these AFP cases.
Public health personnel and pediatricians should
be alerted to the possible role of nonpolio enterovi-
rus infections in the differential diagnosis of AFP or
other severe central nervous system diseases, par-
ticularly in areas where the circulation of wild
poliovirus has been interrupted. The laboratory di-
agnosis of all AFP cases should routinely include
tests capable of detecting EV71 as well as other en-
teroviruses once the primary objective of poliovirus
eradication has been achieved.
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